YOLFTbeta
30

Anhui Sunhere Pharmaceutical Excipients Co Ltd

300452 · SHE · Healthcare / Drug Manufacturers - Specialty & Generic

11.60CNY-0.15 (-1.28%)

Price History

Full chart

Market Stats

Previous Close11.75
Open11.70
Day Range11.59 – 11.85
52-Week Range11.12 – 16.72
Volume2.58M
Market Cap3.11B
P/E (TTM)17.92
Forward P/E0.00
EPS0.74
Dividend Yield2.26%
Beta0.21
50-Day Avg12.75
200-Day Avg13.72

About

Anhui Sunhere Pharmaceutical Excipients Co.,Ltd. engages in the research and development, production, and sale of new pharmaceutical excipients in China. The company provides fillers, adhesives, disintegrants, lubricants, coating materials and other commonly used oral solid preparations. It also offers microcrystalline cellulose, hydroxypropyl methylcellulose, low-substituted hydroxypropyl cellulose, sodium methyl starch, magnesium stearate, and film coating powder, as well as food additive products; and starch, and yellow dextrin products. The company serve textile, papermaking, petroleum, chemical, pharmaceutical, building materials, food, health products, medical aesthetics, cosmetics, and new energy fields. It also exports its products. Anhui Sunhere Pharmaceutical Excipients Co.,Ltd. was founded in 2001 and is based in Huainan, China.

Company Details

  • SectorHealthcare
  • IndustryDrug Manufacturers - Specialty & Generic
  • CEOMr. Dao Cai Song
  • Employees1.13K
  • HeadquartersHuainan Economic and Technological Development Zone,, Huainan, China, 232007, China
  • Websitehttps://www.shanhe01.com

Leadership

  • Mr. Dao Cai SongGM & Non-Independent Director · b. 1970
  • Mr. Qi LiuHead of Finance & Secretary of the Board · b. 1972
  • Ms. Hanfang LeiDeputy GM & Director · b. 1981
  • Mr. Zihu LiuDeputy General Manager · b. 1970
  • Juan YeAccounting Supervisor

Financials

Income Statement

Currency: CNY2011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue143.23M183.88M212.89M239.39M258.92M286.40M339.36M428.56M464.07M531.20M616.71M704.53M839.26M882.57M942.80M
Growth (%)-+28.38%+15.78%+12.45%+8.16%+10.61%+18.49%+26.28%+8.29%+14.47%+16.10%+14.24%+19.12%+5.16%+6.82%
Cost of Revenue97.69M117.86M139.18M162.78M169.22M189.59M234.44M283.21M294.52M366.76M438.93M495.28M573.93M609.34M643.43M
Gross Profit45.54M66.02M73.71M76.61M89.70M96.81M104.92M145.35M169.54M164.44M177.78M209.24M265.33M273.23M299.36M
Gross Margin31.80%35.91%34.62%32.00%34.64%33.80%30.92%33.92%36.53%30.96%28.83%29.70%31.61%30.96%31.75%
Operating Expense22.01M32.60M34.83M41.30M41.99M43.17M44.15M56.98M65.85M55.48M78.07M72.96M79.89M129.96M105.36M
Operating Income23.54M33.43M38.88M35.31M47.71M53.65M60.77M88.37M103.69M108.96M99.71M136.28M185.44M143.27M194.00M
Operating Margin16.43%18.18%18.27%14.75%18.43%18.73%17.91%20.62%22.34%20.51%16.17%19.34%22.10%16.23%20.58%
EBITDA23.58M36.47M42.15M50.95M62.93M69.03M77.09M107.00M123.00M139.65M132.56M173.68M228.90M206.19M265.24M
EBITDA Margin16.46%19.84%19.80%21.28%24.30%24.10%22.72%24.97%26.51%26.29%21.50%24.65%27.27%23.36%28.13%
Net Income21.84M32.16M35.02M34.93M44.27M48.79M50.34M70.11M84.37M93.94M89.25M130.71M161.54M119.42M176.55M
Net Income Margin15.25%17.49%16.45%14.59%17.10%17.03%14.83%16.36%18.18%17.69%14.47%18.55%19.25%13.53%18.73%
R&D-7.51M6.60M6.98M7.34M7.98M8.60M14.20M16.19M18.12M26.80M34.43M41.95M40.95M42.27M
R&D as % of Total Revenue-4.08%3.10%2.92%2.83%2.79%2.53%3.31%3.49%3.41%4.35%4.89%5.00%4.64%4.48%
Interest Expense-49.54K77.54K162.06K151.08K183.36K227.92K221.28K314.55K1.03M1.59M1.61M4.30M13.15M13.14M
Interest Expense % of Total Revenue-0.03%0.04%0.07%0.06%0.06%0.07%0.05%0.07%0.19%0.26%0.23%0.51%1.49%1.39%

Balance Sheet

Currency: CNY2011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets121.51M212.20M233.58M266.39M458.06M512.85M666.40M709.75M810.17M900.87M962.58M1.18B1.54B1.56B1.71B
Total Liabilities25.55M91.03M84.35M89.19M94.86M110.15M166.17M151.86M213.59M245.70M256.67M391.93M607.46M584.43M639.20M
Total Equity95.96M121.17M149.23M177.20M363.20M402.70M441.46M493.09M525.78M585.21M640.00M722.52M866.09M905.01M1.01B
Cash34.23M40.71M30.61M48.00M109.24M117.38M128.02M87.53M99.07M109.32M141.26M150.12M173.96M192.69M299.42M
Total Debt--2.30M6.14M21.82M36.76M64.20M54.21M11.08M39.99M31.04M39.84M297.60M304.98M-
Net Debt-34.23M-40.71M-28.31M-41.86M-87.42M-80.62M-63.82M-33.32M-87.99M-69.33M-110.23M-110.28M123.64M112.29M15.29M

Cash Flow

Currency: CNY2011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-26.41M25.89M36.83M42.66M55.33M63.51M74.76M79.47M85.55M103.82M132.82M142.84M118.33M191.99M
Investing Cash Flow-27.46M-15.99M-31.31M-10.10M-124.29M-38.91M-30.92M-92.27M-30.68M-86.89M-19.84M-88.21M-332.98M-15.01M-
Financing Cash Flow-3.83M-3.95M-4.67M-9.33M142.88M-8.28M-31.99M-20.18M-39.87M8.76M-55.27M-48.52M228.17M-85.21M-
Capital Expenditure28.01M37.73M37.80M11.67M8.87M15.27M25.11M81.81M59.84M21.07M31.47M67.31M54.92M27.94M40.73M
Free Cash Flow-28.01M-11.31M-11.91M25.16M33.79M40.06M38.40M-7.05M19.63M64.48M72.35M65.50M77.38M90.39M151.26M
Dividends Paid3.83M6.96M6.97M7.03M6.96M9.28M19.92M22.57M27.84M34.39M45.10M54.12M59.78M59.01M71.43M
FCF to OCF--42.83%-45.99%68.32%79.21%72.40%60.47%-9.43%24.71%75.38%69.68%49.32%54.17%76.39%78.78%
Dividend Paid to FCF-13.67%-61.53%-58.57%27.95%20.60%23.16%51.87%-320.22%141.79%53.33%62.34%82.62%77.27%65.28%47.22%

Earnings

Report DateJun 30, 2015Sep 30, 2015Feb 25, 2016Apr 27, 2016Aug 19, 2016Oct 27, 2016Feb 20, 2017Apr 26, 2017Aug 24, 2017Oct 27, 2017Dec 31, 2017Apr 26, 2018Aug 23, 2018Oct 24, 2018Feb 25, 2019Apr 25, 2019Aug 23, 2019Oct 21, 2019Feb 21, 2020Apr 27, 2020Aug 21, 2020Oct 16, 2020Feb 22, 2021Apr 19, 2021Aug 27, 2021Oct 27, 2021Dec 31, 2021Apr 28, 2022Aug 1, 2022Oct 25, 2022Dec 31, 2022Apr 20, 2023Aug 2, 2023Oct 24, 2023Apr 25, 2024Aug 28, 2024Oct 22, 2024Apr 22, 2025Aug 27, 2025Oct 21, 2025Apr 24, 2026Aug 24, 2026
EPS Estimate------------------------------------------
EPS Actual0.040.040.060.050.060.040.050.050.060.040.070.110.100.090.080.080.090.090.120.130.110.080.110.170.100.080.070.150.140.120.150.160.170.150.210.190.120.190.190.170.190.20
Surprise------------------------------------------
Timing--After-hoursPre-marketPre-marketAfter-hoursAfter-hoursPre-marketAfter-hoursPre-market-Pre-marketPre-marketAfter-hoursAfter-hoursPre-marketAfter-hoursPre-marketPre-marketAfter-hoursAfter-hoursPre-marketPre-marketAfter-hoursAfter-hoursPre-market-Pre-marketPre-marketPre-market-Pre-marketAfter-hoursPre-marketPre-market-Pre-marketPre-market----

Key Statistics & Ratios

Market Cap3.11B
Enterprise Value2.60B
Trailing P/E17.92
Forward P/E0.00
Price / Sales3.13
Price / Book3.01
EPS0.74
Book Value4.45
Revenue (TTM)993.60M
Gross Profit (TTM)313.91M
EBITDA251.91M
Profit Margin18.09%
Operating Margin19.88%
Return on Equity16.89%
Return on Assets7.31%
Shares Outstanding234.46M
Shares Float143.17M
Beta0.21
Dividend Yield2.26%
Dividend Rate0.30
Payout Ratio53.58%

Dividends

20261×
0.30Jun 10, 2026
20251×
0.30Jun 23, 2025
20241×
0.25May 29, 2024
20231×
0.25May 17, 2023
20221×
0.30May 26, 2022
20211×
0.19May 20, 2021
20201×
0.15May 28, 2020
20191×
0.12May 14, 2019
20181×
0.08Jun 22, 2018
20171×
0.06Jun 2, 2017
20161×
0.04Jun 3, 2016

Stock Splits

  • May 26, 20221.3:1
  • May 28, 20201.3:1
  • Jun 22, 20181.5:1
  • Jun 3, 201620:10